The evolutionary dynamics and fitness landscape of clonal hematopoiesis

Evolutionary dynamics in hematopoiesis Cells accumulate mutations as we age, and these mutations can be a source of diseases such as cancer. How cells containing mutations evolve, are maintained, and proliferate within the body has not been well characterized. Using a quantitative framework, Watson et al. applied population genetic theory to estimate mutation accumulation in cells in blood from sequencing data derived from nearly 50,000 healthy individuals (see the Perspective by Curtis). By evaluating how mutations differ between blood cell populations, a phenomenon known as clonal hematopoiesis, the researchers could observe how recurrent mutations can drive certain clonal lineages to high frequencies within an individual. The risk of specific mutations, some of which are associated with leukemias, rising to high frequencies may therefore be a function of cellular selection and the age at which the mutation originated. Science, this issue p. 1449; see also p. 1426 Blood sequencing data from ~50,000 individuals reveals how mutation, genetic drift, and fitness differences shape the diversity of healthy blood. Somatic mutations acquired in healthy tissues as we age are major determinants of cancer risk. Whether variants confer a fitness advantage or rise to detectable frequencies by chance remains largely unknown. Blood sequencing data from ~50,000 individuals reveal how mutation, genetic drift, and fitness shape the genetic diversity of healthy blood (clonal hematopoiesis). We show that positive selection, not drift, is the major force shaping clonal hematopoiesis, provide bounds on the number of hematopoietic stem cells, and quantify the fitness advantages of key pathogenic variants, at single-nucleotide resolution, as well as the distribution of fitness effects (fitness landscape) within commonly mutated driver genes. These data are consistent with clonal hematopoiesis being driven by a continuing risk of mutations and clonal expansions that become increasingly detectable with age.

[1]  blundell-lab,et al.  blundelllab/ClonalHematopoiesis: The evolutionary dynamics and fitness landscape of clonal hematopoiesis , 2020 .

[2]  Ahmet Zehir,et al.  Oncologic therapy shapes the fitness landscape of clonal hematopoiesis , 2019, bioRxiv.

[3]  Donna Neuberg,et al.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies , 2019, Science.

[4]  L. Wade Was our species in Europe 210,000 years ago? , 2019, Science.

[5]  T. Druley,et al.  Clonal hematopoiesis and risk of acute myeloid leukemia , 2019, Haematologica.

[6]  R. Marioni,et al.  Age-related clonal haemopoiesis is associated with increased epigenetic age , 2019, Current Biology.

[7]  T. Druley,et al.  The evolutionary dynamics and fitness landscape of clonal haematopoiesis , 2019, bioRxiv.

[8]  M. Ye,et al.  Biological background of the genomic variations of cf-DNA in healthy individuals , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  S. Tsunoda,et al.  Age-related remodelling of oesophageal epithelia by mutated cancer drivers , 2019, Nature.

[10]  E. Papaemmanuil,et al.  Managing Clonal Hematopoiesis in Patients With Solid Tumors. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Peter J. Campbell,et al.  Somatic mutant clones colonize the human esophagus with age , 2018, Science.

[12]  P. A. Futreal,et al.  PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy , 2018, Cell stem cell.

[13]  F. Camargo,et al.  Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis , 2018, Cell reports.

[14]  Allon M. Klein,et al.  Epidermal Tissue Adapts to Restrain Progenitors Carrying Clonal p53 Mutations , 2018, Cell stem cell.

[15]  M. Stratton,et al.  The landscape of somatic mutation in normal colorectal epithelial cells , 2018, Nature.

[16]  M. Stratton,et al.  Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.

[17]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[18]  Paolo Vineis,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[19]  T. Yeatman,et al.  Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study. , 2018 .

[20]  Chuang Tan,et al.  Universal Patterns of Selection in Cancer and Somatic Tissues , 2018, Cell.

[21]  Marc J. Williams,et al.  Quantification of subclonal selection in cancer from bulk sequencing data , 2018, Nature Genetics.

[22]  R. Handsaker,et al.  Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.

[23]  A. M. Eren,et al.  Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host , 2018, Nature.

[24]  Wei Li,et al.  Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo , 2018, Cell reports.

[25]  Y. Ba,et al.  Initial dose of apatinib in Chinese patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of stomach or gastroesophageal junction in third- or later-line setting: 500 mg or 850 mg? , 2018 .

[26]  Christopher A. Miller,et al.  Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential , 2018, Nature Communications.

[27]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[28]  Kari Stefansson,et al.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.

[29]  Sasha F. Levy,et al.  The dynamics of adaptive genetic diversity during the early stages of clonal evolution , 2017, Nature Ecology & Evolution.

[30]  Sebastian Bonhoeffer,et al.  Clonal dominance and transplantation dynamics in hematopoietic stem cell compartments , 2017, PLoS Comput. Biol..

[31]  Christian Gilissen,et al.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.

[32]  Gary D Bader,et al.  Tracing the origins of relapse in acute myeloid leukaemia to stem cells , 2017, Nature.

[33]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[34]  D. Neuberg,et al.  Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation , 2017, The New England journal of medicine.

[35]  Erika J. Thompson,et al.  Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study , 2016, The Lancet. Oncology.

[36]  Hans Clevers,et al.  Tissue-specific mutation accumulation in human adult stem cells during life , 2016, Nature.

[37]  Sasha F. Levy,et al.  Development of a Comprehensive Genotype-to-Fitness Map of Adaptation-Driving Mutations in Yeast , 2016, Cell.

[38]  T. Druley,et al.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.

[39]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[40]  B. Simons Deep sequencing as a probe of normal stem cell fate and preneoplasia in human epidermis , 2015, Proceedings of the National Academy of Sciences.

[41]  G. Vassiliou,et al.  Aging as a driver of leukemogenesis , 2015, Science Translational Medicine.

[42]  J. DeGregori,et al.  Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations , 2015, Proceedings of the National Academy of Sciences.

[43]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[44]  S. Miyano,et al.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.

[45]  M. Stratton,et al.  High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.

[46]  E. Zeggini,et al.  Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.

[47]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[48]  M. Hallek,et al.  Value of Minimal Residual Disease (MRD) Negative Status at Response Evaluation in Chronic Lymphocytic Leukemia (CLL): Combined Analysis of Two Phase III Studies of the German CLL Study Group (GCLLSG) , 2014 .

[49]  G. Adelmant,et al.  GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition , 2014 .

[50]  Christopher A. Miller,et al.  The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.

[51]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[52]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[53]  S. Bojesen,et al.  JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate , 2014, Haematologica.

[54]  R. Majeti,et al.  Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis , 2014, Leukemia.

[55]  Lincoln D. Stein,et al.  Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.

[56]  Lincoln D. Stein,et al.  DNMT3a Mutations Define a Pre-Leukemic Stem Cell Reservoir In Human Acute Myeloid Leukemia , 2013 .

[57]  R. Majeti,et al.  Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia , 2013, International Journal of Hematology.

[58]  I. Weissman,et al.  Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.

[59]  M. Manz,et al.  Demand-adapted regulation of early hematopoiesis in infection and inflammation. , 2012, Blood.

[60]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[61]  J. Taminau,et al.  InSilico DB: an online platform to collaboratively structure and export publicly available datasets from the Gene Expression Omnibus database , 2011, Genome Biology.

[62]  M. Goodell,et al.  Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response , 2011, Nature Reviews Immunology.

[63]  D. Horvath,et al.  Two-photon laser spectroscopy of antiprotonic helium and the antiproton-to-electron mass ratio , 2011, Nature.

[64]  Leonard I. Zon,et al.  Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal , 2008, Nature.

[65]  Allon M Klein,et al.  Kinetics of cell division in epidermal maintenance. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[66]  Benjamin D. Simons,et al.  A single type of progenitor cell maintains normal epidermis , 2007, Nature.

[67]  Michael M. Desai,et al.  Beneficial Mutation–Selection Balance and the Effect of Linkage on Positive Selection , 2006, Genetics.

[68]  R. Tarone,et al.  Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Delbrück,et al.  Mutations of Bacteria from Virus Sensitivity to Virus Resistance. , 1943, Genetics.